Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients
Journal of Hematopathology · 2024
DOI: 10.1007/s12308-024-00579-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematopathology, 2024. Verfasst von Marie-France Gagnon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Gene Rearrangement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
MYC -rearranged B-cell lymphoma (BCL) in the pediatric/young adult (YA) age group differs substantially in disease composition from adult cohorts. However, data regarding the partner genes, concurrent rearrangements, and ultimate diagnoses in these patients is scarce compared to that in adult cohorts. We aimed to characterize the spectrum of MYC -rearranged ( MYC -R) mature, aggressive BCL in the pediatric/YA population. A retrospective study of morphologic, immunophenotypic, and fluorescence in situ hybridization (FISH) results of patients age ≤ 30 years with suspected Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBCL), and a MYC -R by FISH between 2013–2022 was performed. Two-hundred fifty-eight cases (129 (50%) pediatric (< 18 years) and 129 (50%) YA (18–30 years)) were included. Most MYC -R BCL in pediatric (89%) and YA (66%) cases were BL. While double-hit (DH) cytogenetics ( MYC with BCL2 and/or BCL6 -R, HGBCL-DH) was rare in the pediatric population (2/129, 2%), HGBCL-DH increased with age and was identified in 17/129 (13%) of YA cases. Most HGBCL-DH had MYC and BCL6 -R, while BCL2 -R were rare in both groups (3/258, 1%). MYC -R without an IG partner was more common in the YA group (14/116 (12%) vs 2/128 (2%), p = 0.001). The pediatric to YA transition is characterized by decreasing frequency in BL and increasing genetic heterogeneity of MYC -R BCL, with emergence of DH-BCL with MYC and BCL6 -R. FISH to evaluate for BCL2 and BCL6 rearrangements is likely not warranted in the pediatric population but should continue to be applied in YA BCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. king.rebecca1@mayo.edu.
Zitieren
APA
Gagnon, M. F., Bruehl, F. K., Sill, D. R., Meyer, R. G., Greipp, P. T., Hoppman, N. L., Xu, X., Baughn, L. B., Peterson, J. F., McPhail, E. D., Ketterling, R. P., & King, R. L. (2024). Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of Hematopathology. https://doi.org/10.1007/s12308-024-00579-6
Vancouver
Gagnon MF, Bruehl FK, Sill DR, Meyer RG, Greipp PT, Hoppman NL, et al. Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of Hematopathology. 2024. doi:10.1007/s12308-024-00579-6
BibTeX
@article{Gagnon2024,
author = {Gagnon, Marie-France and Bruehl, Frido K and Sill, Daniel R and Meyer, Reid G and Greipp, Patricia T and Hoppman, Nicole L and Xu, Xinjie and Baughn, Linda B and Peterson, Jess F and McPhail, Ellen D and Ketterling, Rhett P and King, Rebecca L},
title = {Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients},
journal = {Journal of Hematopathology},
year = {2024},
doi = {10.1007/s12308-024-00579-6}
}
EUVIMED